Wegovy BMI Requirement UK - Eligibility & Price £69.00

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy BMI Requirement UK Price - From £69.00

Get Wegovy at the cheapest UK price from £69.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding the Wegovy BMI Requirement UK: Eligibility Criteria for Prescription Weight Loss

The Wegovy BMI requirement UK is a crucial factor in determining eligibility for this prescription weight loss treatment. At Cured Pharmacy, we help patients understand whether they meet the clinical criteria for semaglutide therapy, which typically requires a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity[1]. Our UK-registered clinical team assesses each patient individually to ensure safe, appropriate prescribing in line with MHRA and NICE guidance.

What Is the Wegovy BMI Requirement UK for Prescription Eligibility?

The Wegovy BMI requirement UK follows established clinical guidelines that prioritise patient safety and treatment appropriateness. In the UK, Wegovy (semaglutide 2.4mg) is licensed for adults with a body mass index of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea[1]. These thresholds align with NICE recommendations and reflect the inclusion criteria used in the pivotal STEP clinical trial programme[2].

At Cured Pharmacy, our prescribers assess each patient's BMI alongside their medical history, current medications, and weight loss goals during a free online consultation. This individualised approach ensures that Wegovy is prescribed only when clinically appropriate and when lifestyle interventions alone have not achieved sufficient weight loss. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical protocols to maintain the highest standards of patient care and regulatory compliance.

How BMI Thresholds for Wegovy Prescription Are Calculated in the UK

Understanding your BMI is the first step in determining whether you meet the Wegovy BMI requirement UK criteria. Body mass index is calculated by dividing your weight in kilograms by the square of your height in metres (kg/m²). For example, a person weighing 90kg and standing 1.75m tall would have a BMI of approximately 29.4 kg/m². This simple calculation provides a standardised measure that UK prescribers use to assess obesity and weight-related health risks[3].

However, BMI is not the sole determinant of eligibility. UK prescribers also consider waist circumference, ethnicity-specific risk factors, and the presence of comorbid conditions. For individuals of South Asian, Chinese, or Black African descent, lower BMI thresholds may apply due to increased metabolic risk at lower body weights[1]. At Cured Pharmacy, our clinical assessment captures these nuances to ensure equitable access to Wegovy for all eligible patients, regardless of ethnic background.

Comorbidities That Lower the Wegovy BMI Requirement UK Threshold

Patients with a BMI of 27 kg/m² or above may qualify for Wegovy if they have at least one weight-related comorbidity. These include type 2 diabetes, prediabetes, hypertension, dyslipidaemia, cardiovascular disease, non-alcoholic fatty liver disease, polycystic ovary syndrome, or obstructive sleep apnoea[2]. The presence of these conditions significantly increases the health risks associated with excess weight, making pharmacological intervention clinically justified even at a lower BMI threshold.

During your online consultation at Cured Pharmacy, you will be asked to disclose any diagnosed comorbidities and current medications. This information allows our prescribers to assess whether you meet the expanded Wegovy BMI requirement UK criteria and whether semaglutide therapy is safe and appropriate for your individual circumstances. All consultations are conducted by UK-registered clinicians and typically take under three minutes to complete.

Clinical Evidence Supporting the Wegovy BMI Requirement UK Guidelines

The Wegovy BMI requirement UK is grounded in robust clinical trial data from the STEP programme, which enrolled over 4,500 adults with obesity or overweight with comorbidities. In the landmark STEP 1 trial, participants with a mean baseline BMI of 37.9 kg/m² achieved an average weight loss of 14.9% over 68 weeks when treated with semaglutide 2.4mg, compared to 2.4% with placebo[2]. These results demonstrated that Wegovy is highly effective in the target population defined by current BMI thresholds.

Importantly, subgroup analyses showed consistent efficacy across different baseline BMI categories, including those with BMI 27-30 kg/m² who had weight-related comorbidities. This evidence supports the dual-threshold approach used in UK prescribing guidelines and reinforces the importance of individualised assessment. At Cured Pharmacy, we provide Wegovy at £69.00 ensuring that eligible patients can access this evidence-based treatment at competitive UK pricing, subject to prescriber approval.

Treatment Minimum BMI Type Starting Price
Wegovy 30 (or 27 with comorbidities) Weekly injection from £89.00
Mounjaro 30 (or 27 with comorbidities) Weekly injection from £145.00
Saxenda 30 (or 27 with comorbidities) Daily injection from £68.00
Orlistat 28 Oral capsule from £32.00
Mysimba 30 (or 27 with comorbidities) Oral tablet from £125.95

What to Expect During Your Wegovy BMI Requirement UK Assessment at Cured Pharmacy

Your journey begins with a free online clinical assessment that evaluates whether you meet the Wegovy BMI requirement UK criteria. You will be asked to provide your current height and weight, medical history, current medications, and details of any weight-related health conditions. Our UK-registered prescribers review this information to calculate your BMI and determine whether Wegovy is a safe and appropriate option for you[3].

If approved, your prescription is issued electronically and dispensed by our GPhC-registered pharmacy (9012511). Wegovy is available from £69.00 and we offer discreet next-day delivery across the UK. All medicines are genuine, UK-licensed products sourced from reputable wholesalers. Our transparent pricing means you see the full cost upfront, with no hidden fees or subscription traps. New customers can Save £20 off their first order using code Weightlossnew.

Common Reasons for Not Meeting the Wegovy BMI Requirement UK Criteria

Some patients may not meet the Wegovy BMI requirement UK thresholds due to a BMI below 27 kg/m², absence of weight-related comorbidities, or contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2[1]. Pregnant or breastfeeding women are also ineligible, as are individuals with severe gastrointestinal disease or a history of pancreatitis.

If you do not qualify for Wegovy, our prescribers may recommend alternative weight loss treatments such as Orlistat, Mysimba, or Saxenda, depending on your clinical profile. Cured Pharmacy offers a comprehensive range of MHRA-licensed weight loss medications, all subject to the same rigorous clinical assessment process to ensure patient safety and treatment efficacy.

How the Wegovy BMI Requirement UK Compares to Other Weight Loss Medications

While the Wegovy BMI requirement UK is set at 30 kg/m² or 27 kg/m² with comorbidities, other weight loss medications have different eligibility criteria. Orlistat, for example, is licensed for individuals with a BMI of 28 kg/m² or above, making it accessible to a slightly broader population[3]. Saxenda (liraglutide 3mg) shares the same BMI thresholds as Wegovy, while Mounjaro (tirzepatide) follows similar criteria but is primarily licensed for type 2 diabetes, with weight loss as a secondary benefit.

Understanding these differences helps patients and prescribers select the most appropriate treatment. At Cured Pharmacy, we stock all major weight loss medications and provide clear, evidence-based guidance during your consultation. Our clinical team considers your BMI, comorbidities, previous treatment responses, and personal preferences to recommend the option most likely to achieve safe, sustainable weight loss.

Maintaining Eligibility: Ongoing Monitoring After Meeting the Wegovy BMI Requirement UK

Meeting the Wegovy BMI requirement UK is only the first step in a longer-term weight management programme. NICE guidance recommends that patients are reviewed after 12 weeks of treatment to assess response, defined as at least 5% weight loss from baseline[1]. If this threshold is not met, continuation of Wegovy may not be appropriate, and alternative strategies should be considered.

At Cured Pharmacy, we support ongoing treatment through repeat prescription services and access to our clinical team for any questions or concerns. We encourage patients to combine Wegovy with lifestyle modifications, including a reduced-calorie diet and increased physical activity, as recommended in all major clinical trials[2]. Our pharmacists are available by phone (+44 116 4646009) to provide guidance on injection technique, managing side effects, and optimising treatment outcomes. All follow-up prescriptions are subject to continued clinical suitability and prescriber approval.

What Happens If Your BMI Falls Below the Wegovy Requirement UK Threshold During Treatment?

As you lose weight on Wegovy, your BMI will naturally decrease. If your BMI falls below the original Wegovy BMI requirement UK threshold of 30 kg/m² (or 27 kg/m² with comorbidities), your prescriber will assess whether continued treatment is appropriate. In many cases, Wegovy may be continued for weight maintenance, particularly if discontinuation has previously led to weight regain or if significant comorbidities persist[2].

Clinical judgement is paramount in these decisions. Some patients may transition to a lower maintenance dose, while others may discontinue Wegovy and focus on lifestyle measures alone. At Cured Pharmacy, our prescribers apply a patient-centred approach that balances clinical guidelines with individual circumstances, always prioritising long-term health outcomes over rigid adherence to BMI thresholds.

Scientific References

  1. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity (TA875). NICE. [accessed 15 August 2026]
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  3. Medicines and Healthcare products Regulatory Agency. (2023). Public assessment report: Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen. MHRA. [accessed 15 August 2026]
  4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What is the minimum BMI for Wegovy in the UK?
The Wegovy BMI requirement UK is 30 kg/m² or above, or 27 kg/m² or above if you have at least one weight-related comorbidity such as type 2 diabetes or hypertension.
Can I get Wegovy with a BMI of 28 in the UK?
A BMI of 28 kg/m² may qualify you for Wegovy if you have a diagnosed weight-related comorbidity, subject to prescriber assessment at Cured Pharmacy.
Do I need to see a GP to check my BMI for Wegovy?
No, you can complete a free online consultation at Cured Pharmacy where our UK-registered prescribers will calculate your BMI and assess your eligibility for Wegovy.
What comorbidities allow a lower Wegovy BMI requirement UK threshold?
Qualifying comorbidities include type 2 diabetes, hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea, and polycystic ovary syndrome, among others.
How accurate is BMI for determining Wegovy eligibility?
BMI is a useful screening tool, but UK prescribers also consider waist circumference, ethnicity, muscle mass, and overall health status when assessing Wegovy suitability.
Can I use Wegovy if I have a BMI over 40?
Yes, Wegovy is licensed for all BMI levels of 30 kg/m² and above, including those with severe obesity (BMI ≥40), subject to prescriber approval and absence of contraindications.
Will Cured Pharmacy calculate my BMI during the consultation?
Yes, when you provide your height and weight during the online assessment, our system calculates your BMI automatically and our prescribers review it as part of your eligibility evaluation.
What happens if I don't meet the Wegovy BMI requirement UK criteria?
If you don't meet the BMI threshold, our prescribers may recommend alternative weight loss treatments such as Orlistat or lifestyle interventions, depending on your individual circumstances.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.